Literature DB >> 8968432

Lessons from combination therapy in Veterans Affairs Studies. Department of Veterans Affairs Cooperative Study Group on antihypertensive agents.

B J Materson1, D J Reda, D Williams.   

Abstract

A subset of 102 patients of an original cohort of 1292 with stage 1 to 2 hypertension was characterized by having failed to achieve goal blood pressure (< 90 mm Hg diastolic) after treatment with two single antihypertensive drugs. These patients were given a combination of the two drugs on which they had failed to achieve blood pressure goal when they were administered as single-drug therapy. The drugs were hydrochlorothiazide, atenolol, captopril, diltiazem-SR, clonidine, and prazosin. We examined the responses in each of the drug combination categories by the order that the drugs were administered, by estimated total response rates for the combinations, and by age and race. The order of drug administration did have an effect for some of the drug pairs. This was of two types: 1) different results for each member of the pair, but the same combination result; and 2) different end result of the combination. An example of the first type is that prazosin had only a 6% response rate in patients who had failed on diltiazem, while diltiazem had a 22% response rate in patients who had failed on prazosin. Nevertheless, the combinations yielded the same total responses (86% and 84%) regardless of order. An example of the second type is that captopril-diltiazem was less effective in total response than diltiazem-captopril (88% v 97%). Differences were seen in the response to combinations in the race and age groups. There were ordering differences of type similar to those described above. We conclude that combination drug therapy is highly effective even when the individual components have failed and that some differences in response by order of drug administration may occur.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8968432     DOI: 10.1016/s0895-7061(96)00389-5

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  10 in total

Review 1.  Rationale for fixed-dose combinations in the treatment of hypertension: the cycle repeats.

Authors:  Domenic A Sica
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 2.  Hypertension in black patients: special issues and considerations.

Authors:  Shawna D Nesbitt
Journal:  Curr Cardiol Rep       Date:  2004-11       Impact factor: 2.931

Review 3.  Hypertension in black patients: special issues and considerations.

Authors:  Shawna D Nesbitt
Journal:  Curr Hypertens Rep       Date:  2005-08       Impact factor: 5.369

Review 4.  Racial differences in blood pressure response to calcium channel blocker monotherapy: a meta-analysis.

Authors:  Thu T Nguyen; Jay S Kaufman; Eric A Whitsel; Richard S Cooper
Journal:  Am J Hypertens       Date:  2009-06-04       Impact factor: 2.689

5.  Polytherapy with two or more antihypertensive drugs to lower blood pressure in elderly Ontarians. Room for improvement.

Authors:  Norman R C Campbell; Finlay A McAlister; Minh Duong-Hua; Karen Tu
Journal:  Can J Cardiol       Date:  2007-08       Impact factor: 5.223

6.  Hypertension control among African Americans: an urgent call for action.

Authors:  Daniel T Lackland
Journal:  J Clin Hypertens (Greenwich)       Date:  2004-06       Impact factor: 3.738

7.  Hypertension and end-organ disease in African Americans: case presentations.

Authors:  Domenic A Sica
Journal:  J Clin Hypertens (Greenwich)       Date:  2004-04       Impact factor: 3.738

Review 8.  Hypertension-related morbidity and mortality in African Americans--why we need to do better.

Authors:  Keith C Ferdinand; Elijah Saunders
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-01       Impact factor: 3.738

Review 9.  Treating stage 2 hypertension.

Authors:  Thomas D Giles; Barry J Materson
Journal:  J Clin Hypertens (Greenwich)       Date:  2005-08       Impact factor: 3.738

Review 10.  Rationale for combination therapy in the management of hypertension.

Authors:  Marvin Moser
Journal:  J Clin Hypertens (Greenwich)       Date:  2003 Nov-Dec       Impact factor: 3.738

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.